The FDA's decision comes after the company said it had paused the mid-stage trial of the drug, zetomipzomib, to review safety ...

For Ysabella Amara, 16, living in the UAE's year-round sunshine means she must battle more than the usual challenges of ...

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system lupus, can be challenging to diagnose ...

Doctors in China said a homegrown cell therapy saw initial success in children with a severe autoimmune disorder, the latest ...

The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged four deaths during the phase 2b study.

A new study suggests that your morning cup of coffee might do more than just wake you up – it could be giving your blood ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...

To provide more robust evidence for clinicians, investigators analyzed the efficacy and safety of biologics in patients with lupus nephritis using meta-regression analyses that adjusted for trials’ ...

Lupus nephritis, a kidney disease-related manifestation of the most common lupus type, systemic lupus erythematosus (SLE), ...

In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for increasing ...

The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences' trial of experimental drug for lupus ...